Charter Oak Capital Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-22
Closed -$1K 916
2022
Q1
$1K Hold
22
﹤0.01% 915
2021
Q4
$1K Hold
22
﹤0.01% 799
2021
Q3
$1K Buy
22
+4
+22% +$136 ﹤0.01% 772
2021
Q2
$1K Hold
18
﹤0.01% 759
2021
Q1
$1K Hold
18
﹤0.01% 730
2020
Q4
$1K Buy
+18
New +$749 ﹤0.01% 691

Other funds holding AVNS

Charter Oak Capital Management's AVNS Position: Q2 2022 in Review

Charter Oak Capital Management sold out of Avanos Medical (AVNS) in Q2 2022, closing a stake of 22 shares — an estimated $1K sold.

Charter Oak Capital Management first reported a position in AVNS in Q4 2020 and held it in 6 quarters. The position peaked at $1K in Q1 2022. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

  • Charter Oak Capital Management reported no remaining Avanos Medical position as of Q2 2022 after selling out during the quarter.
  • Charter Oak Capital Management sold 22 Avanos Medical shares in Q2 2022, an estimated $1K.
  • Charter Oak Capital Management first reported a position in Avanos Medical in Q4 2020 and held it in 6 quarters.
  • Charter Oak Capital Management's Avanos Medical position peaked at $1K in Q1 2022.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on Charter Oak Capital Management's 13F filing for Q2 2022, filed 21 Jul 2022.